Skip to main content
Clinical Trials/CTRI/2017/06/008751
CTRI/2017/06/008751Completed未知

Impact of treatment of vitamin D deficiency on platelet response in immune thrombocytopenia patients

JIPMER0 sites101 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
JIPMER
Enrollment
101

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Newly diagnosed patients (age more than or equal to 13years) of ITP (diagnosed within 1 month of enrolment for present study)
  • Patients (age more than or equal to 13 years) already diagnosed to be having ITP (diagnosed for >1 month before enrollment to present study) and with platelet count between 20000-50000/µl on stable/decreasing dose of steroids/immunosuppressants/immunomodulators.

Exclusion Criteria

  • Group A and Group B
  • (i) Cases of Evanâ??s syndrome
  • (ii) Cases of SLE, HCV infection (secondary
  • (iii) Those patients who have already received replacement doses of vitamin D before enrolment
  • into the study
  • (iv) Patients who are having already diagnosed
  • malabsorption syndrome, chronic kidney
  • (v) Patients who are on antiepileptics before
  • enrolling into the study.
  • In addition to these those patients having mucosal bleeds and severe cutaneous bleeds(Extensive ecchymoses) will be excluded in group B

Investigators

Sponsor
JIPMER

Similar Trials